Accès gratuit
| Numéro |
Med Sci (Paris)
Volume 34, Numéro 10, Octobre 2018
|
|
|---|---|---|
| Page(s) | 765 - 768 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2018201 | |
| Publié en ligne | 19 novembre 2018 | |
- Guignabert C, Tu L, Girerd B, et al. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication. Chest 2015 ; 147 : 529–537. [CrossRef] [PubMed] [Google Scholar]
- Perros F, Humbert M, Cohen-Kaminski S, Hypertension pulmonaire artérielle : un parfum d’auto-immunité. Med Sci (Paris) 2013 ; 29 : 607–616. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Cracowski JL, Chabot F, Labarere J, et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J 2014 ; 43 : 915–917. [CrossRef] [PubMed] [Google Scholar]
- Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010 ; 122 : 920–927. [CrossRef] [PubMed] [Google Scholar]
- Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995 ; 151 : 1628–1631. [CrossRef] [PubMed] [Google Scholar]
- Ricard N, Tu L, , Le Hiress M, et al. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension. Circulation 2014 ; 129 : 1586–1597. [CrossRef] [PubMed] [Google Scholar]
- Savale L, Tu L, Rideau D, et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 2009 ; 10 : 6. [CrossRef] [PubMed] [Google Scholar]
- Tamura Y, Phan C, Tu L, et al. Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. J Clin Invest 2018 ; 128 : 1956–1970. [CrossRef] [PubMed] [Google Scholar]
- Golembeski SM, West J, Tada Y, Fagan KA. Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice. Chest 2005 ; 128 : S572–S573. [CrossRef] [Google Scholar]
- Steiner MK, Syrkina OL, Kolliputi N, et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009; 104 : 236–44, 28p following 44. [CrossRef] [Google Scholar]
- Le Hiress M, Tu L, Ricard N, et al. Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor/CD74 complex. Am J Respir Crit Care Med 2015 ; 192 : 983–997. [CrossRef] [PubMed] [Google Scholar]
- Hashimoto-Kataoka T, Hosen N, Sonobe T, et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci USA 2015 ; 112 : E2677–E2686. [CrossRef] [Google Scholar]
- Jasiewicz M, Knapp M, Waszkiewicz E, et al. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Cytokine 2015 ; 76 : 187–192. [CrossRef] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.